An evaluation of race, ethnicity, age, and sex-based representation in phase I to II renal cell carcinoma clinical trials in the United States

Enrollment of a representative study population permits generalizable and reliable results for clinical trials. We sought to evaluate whether patients enrolled in trials for advanced renal cell carcinoma (RCC) are representative of the overall population of advanced RCC patients in the United States.

Source: Urologic Oncology: Seminars and Original Investigations - June 6, 2018 Category: Urology & Nephrology Authors: Alain Kaldany, Kyle A. Blum, David J. Paulucci, Alp Tuna Beksac, Isuru Jayaratna, John P. Sfakianos, Ketan K. Badani Tags: Original article Source Type: research